Get the Stockscreener App
112.56
1.83%
2.02
After Hours:
112.56
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $112.56, with a volume of 1.74M.
It is up +1.83% in the last 24 hours and up +1.10% over the past month.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
See More
Previous Close:
$110.54
Open:
$110.15
24h Volume:
1.74M
Relative Volume:
2.04
Market Cap:
$13.70B
Revenue:
$2.72B
Net Income/Loss:
$254.30M
P/E Ratio:
18.93
EPS:
5.9463
Net Cash Flow:
$564.37M
1W Performance:
-2.92%
1M Performance:
+1.10%
6M Performance:
+4.71%
1Y Performance:
+8.18%
1-Day Range:
$110.15
$113.66
1-Week Range:
$107.64
$117.41
52-Week Range:
$97.31
$129.50
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
112.56 | 13.70B | 2.72B | 254.30M | 564.37M | 2.0665 |
|
TMO
Thermo Fisher Scientific Inc
|
524.05 | 200.45B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
228.55 | 165.08B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
134.51 | 38.36B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.27 | 35.80B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
412.26 | 33.76B | 3.84B | 866.24M | 792.60M | 10.37 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-08-24 | Initiated | Leerink Partners | Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
How To YieldBoost Revvity To 12.8% Using Options - Nasdaq
Why Revvity, Inc. (NYSE:RVTY) Could Be Worth Watching - Simply Wall St
Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Revvity Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Revvity CEO to Present Strategic Vision at J.P. Morgan Healthcare Conference 2025 - StockTitan
Jane Street Group LLC Sells 164,156 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Trend Tracker for (RVTY) - Stock Traders Daily
Revvity Inc. stock underperforms Monday when compared to competitors - MarketWatch
Safe Biopharma: Revvity’s Recurring Revenues And Diagnostics (NYSE:RVTY) - Seeking Alpha
Tidal Investments LLC Buys 50,666 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity, Inc. (NYSE:RVTY) Shares Purchased by Geode Capital Management LLC - MarketBeat
Revvity Inc. stock underperforms Friday when compared to competitors - MarketWatch
Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst - Benzinga
Revvity (NYSE:RVTY) Raised to Buy at Bank of America - MarketBeat
Revvity Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Fmr LLC Purchases 45,040 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Can Revvity, Inc. (NYSE:RVTY) Performance Keep Up Given Its Mixed Bag Of Fundamentals? - Yahoo Finance
State Street Corp Acquires 17,832 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity, Inc. (NYSE:RVTY) Shares Sold by First National Bank of Omaha - MarketBeat
Quantinno Capital Management LP Has $5.58 Million Stock Holdings in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Trading (RVTY) With Integrated Risk Controls - Stock Traders Daily
Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch
Why Is Revvity (RVTY) Down 8.7% Since Last Earnings Report? - MSN
Cinctive Capital Management LP Makes New $2.31 Million Investment in Revvity, Inc. (NYSE:RVTY) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 48,700 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Raises Stake in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Verition Fund Management LLC Has $8.41 Million Stake in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Timber Creek Capital Management LLC Acquires 4,336 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Bank of Montreal Can Trims Stock Position in Revvity, Inc. (NYSE:RVTY) - MarketBeat
BNP Paribas Financial Markets Trims Stake in Revvity, Inc. (NYSE:RVTY) - MarketBeat
RVTY (Revvity) EV-to-Revenue : 5.96 (As of Nov. 29, 2024) - GuruFocus.com
Gene Editing Market Forecast Report 2024, with Profiles of Merck, GenScript, Revvity, Lonza, Precision BioSciences, Cellectis, AMSBIO, Synthego, Takara Bio, Bio-Techne, Reprocell and More - Yahoo Finance
Revvity, Inc. (NYSE:RVTY) Shares Sold by Citigroup Inc. - MarketBeat
Revvity broadens relationship with Genomics England to advance genomics in the UK - SelectScience
Zacks Research Issues Positive Outlook for Revvity Earnings - MarketBeat
The Manufacturers Life Insurance Company Acquires 27,825 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
FY2024 EPS Estimates for Revvity Boosted by Zacks Research - MarketBeat
Revvity Inc. stock rises Tuesday, still underperforms market - MarketWatch
What Are Wall Street Analysts' Target Price for Revvity Stock? - Nasdaq
What Are Wall Street Analysts' Target Price For Revvity Stock? - Barchart
Revvity Broadens Relationship With Genomics England To Advance Genomics in the UK - Technology Networks
Revvity price target lowered to $135 from $140 at Barclays - Yahoo Finance
Revvity, Inc. (NYSE:RVTY) Shares Purchased by Charles Schwab Investment Management Inc. - MarketBeat
Pathstone Holdings LLC Acquires 8,791 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Brokerages Set Revvity, Inc. (NYSE:RVTY) Price Target at $131.73 - MarketBeat
RVTY (Revvity) Shares Outstanding (EOP) : 122 Mil (As of Sep. 2024) - GuruFocus.com
Barclays Has Lowered Expectations for Revvity (NYSE:RVTY) Stock Price - MarketBeat
Q1 Earnings Forecast for Revvity Issued By Leerink Partnrs - MarketBeat
Wells Fargo Initiates Coverage of Revvity (RVTY) with Equal-Weight Recommendation - MSN
Primecap Management Co. CA Lowers Holdings in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):